Coeur Mining Revenue Doubles on Higher Gold Prices and New Gold Deal, but Valuation Limits Upside

What happened

Coeur Mining's Q1 2026 revenue more than doubled year over year, driven by elevated precious metals prices, operating leverage, and its transformational New Gold acquisition. The New Gold deal boosted gold equivalent reserves by 46% and measured and indicated resources by 68%, reinforcing the scale-up story. However, at $19.11, the stock trades at 38x EV/EBITDA and 30x P/E, leaving limited margin of safety for execution misses at Rochester or delays in the New Gold closure. The deep-value analysis flags that Rochester expansion remains execution-fragile and Las Chispas integration introduces accounting noise from purchase price allocation. While the headline revenue growth is strong, the stock's elevated valuation means further upside requires flawless execution and closure of the New Gold deal in H1 2026.

Implication

The doubling of Q1 revenue confirms operational momentum and scale benefits from acquisitions, but the market has already largely priced this in. With 38x EV/EBITDA, the stock offers almost no margin of safety for operational or regulatory setbacks, such as a delay in Investment Canada Act approval. The key near-term catalysts are the FY2025 earnings release (Feb 2026) and New Gold closing; any delay could trigger a sharp re-rating lower. Insider selling clustered in August-September 2025 at prices well below current levels suggests some management took profits early. Until the Investment Canada Act approval is secured and 2026 guidance confirms production and cost targets, the risk/reward remains unattractive at current prices.

Thesis delta

The news of a doubled Q1 revenue and significant reserve/resource boost from New Gold confirms the operational scale-up narrative, but our thesis remains cautious because valuation already prices in this success. The key shift is that the market narrative is now fully focused on deal closure and 2026 guidance, moving from 'turnaround' to 'delivery' phase. We see no reason to upgrade from WAIT until the stock de-risks toward our attractive entry of $15.